174 related articles for article (PubMed ID: 28554217)
21. Uric acid and late-onset Alzheimer's disease: results from the ReGAl 2.0 project.
Boccardi V; Carino S; Marinelli E; Lapenna M; Caironi G; Bianco AR; Cecchetti R; Ruggiero C; Mecocci P;
Aging Clin Exp Res; 2021 Feb; 33(2):361-366. PubMed ID: 32277437
[TBL] [Abstract][Full Text] [Related]
22. Oxidative stress in blood in Alzheimer's disease and mild cognitive impairment: a meta-analysis.
Schrag M; Mueller C; Zabel M; Crofton A; Kirsch WM; Ghribi O; Squitti R; Perry G
Neurobiol Dis; 2013 Nov; 59():100-10. PubMed ID: 23867235
[TBL] [Abstract][Full Text] [Related]
23. Cerebrospinal fluid diagnostic markers correlate with lower plasma copper and ceruloplasmin in patients with Alzheimer's disease.
Kessler H; Pajonk FG; Meisser P; Schneider-Axmann T; Hoffmann KH; Supprian T; Herrmann W; Obeid R; Multhaup G; Falkai P; Bayer TA
J Neural Transm (Vienna); 2006 Nov; 113(11):1763-9. PubMed ID: 16736242
[TBL] [Abstract][Full Text] [Related]
24. 'Free' copper in serum of Alzheimer's disease patients correlates with markers of liver function.
Squitti R; Ventriglia M; Barbati G; Cassetta E; Ferreri F; Dal Forno G; Ramires S; Zappasodi F; Rossini PM
J Neural Transm (Vienna); 2007; 114(12):1589-94. PubMed ID: 17641816
[TBL] [Abstract][Full Text] [Related]
25. Serum Non-Ceruloplasmin Non-Albumin Copper Elevation in Mild Cognitive Impairment and Dementia due to Alzheimer's Disease: A Case Control Study.
Rozzini L; Lanfranchi F; Pilotto A; Catalani S; Gilberti ME; Paganelli M; Apostoli P; Padovani A
J Alzheimers Dis; 2018; 61(3):907-912. PubMed ID: 29332043
[TBL] [Abstract][Full Text] [Related]
26. A relation of serum homocysteine, uric acid and C-reactive protein level in patients with acute myocardial infarction.
Marković Boras M; Čaušević A; Brizić I; Mikulić I; Vasilj M; Jelić Knezović N
Med Glas (Zenica); 2018 Aug; 15(2):101-108. PubMed ID: 30047537
[TBL] [Abstract][Full Text] [Related]
27. Platelet Total PLA
Balietti M; Casoli T; Giacconi R; Giuli C
Rejuvenation Res; 2022 Feb; 25(1):16-24. PubMed ID: 34913745
[TBL] [Abstract][Full Text] [Related]
28. Longitudinal analysis of serum copper and ceruloplasmin in Alzheimer's disease.
Rembach A; Doecke JD; Roberts BR; Watt AD; Faux NG; Volitakis I; Pertile KK; Rumble RL; Trounson BO; Fowler CJ; Wilson W; Ellis KA; Martins RN; Rowe CC; Villemagne VL; Ames D; Masters CL; AIBL research group ; Bush AI
J Alzheimers Dis; 2013; 34(1):171-82. PubMed ID: 23168449
[TBL] [Abstract][Full Text] [Related]
29. The evaluation of thiol-disulfıte balance, ischemıa albumın modıfıcation and seruloplazmine as a new oxidatıve stress in mild cognitive impairment and early stage alzheimer's disease patients.
Gündüztepe Y; Bukan N; Zorlu E; Karaman Y; Andaç Topkan T; Gurbuz N; Neşelioğlu S; Erel Ö
J Clin Neurosci; 2020 May; 75():188-194. PubMed ID: 32223973
[TBL] [Abstract][Full Text] [Related]
30. Increased tissue factor pathway inhibitor and homocysteine in Alzheimer's disease.
Piazza F; Galimberti G; Conti E; Isella V; Perlangeli MV; Speranza T; Borroni B; Pogliani EM; Padovani A; Ferrarese C
Neurobiol Aging; 2012 Feb; 33(2):226-33. PubMed ID: 20359777
[TBL] [Abstract][Full Text] [Related]
31. Copper, ceruloplasmin and superoxide dismutase in patients with Alzheimer's disease . a case-control study.
Snaedal J; Kristinsson J; Gunnarsdóttir S; Olafsdóttir ; Baldvinsson M; Jóhannesson T
Dement Geriatr Cogn Disord; 1998; 9(5):239-42. PubMed ID: 9701674
[TBL] [Abstract][Full Text] [Related]
32. Cerebrospinal fluid levels of transition metals in patients with Alzheimer's disease.
Molina JA; Jiménez-Jiménez FJ; Aguilar MV; Meseguer I; Mateos-Vega CJ; González-Muñoz MJ; de Bustos F; Porta J; Ortí-Pareja M; Zurdo M; Barrios E; Martínez-Para MC
J Neural Transm (Vienna); 1998; 105(4-5):479-88. PubMed ID: 9720975
[TBL] [Abstract][Full Text] [Related]
33. Clinical utility of copper, ceruloplasmin, and metallothionein plasma determinations in human neurodegenerative patients and their first-degree relatives.
Arnal N; Cristalli DO; de Alaniz MJ; Marra CA
Brain Res; 2010 Mar; 1319():118-30. PubMed ID: 20026314
[TBL] [Abstract][Full Text] [Related]
34. Homeostasis of metals in the progression of Alzheimer's disease.
González-Domínguez R; García-Barrera T; Gómez-Ariza JL
Biometals; 2014 Jun; 27(3):539-49. PubMed ID: 24668390
[TBL] [Abstract][Full Text] [Related]
35. Plasma homocysteine in Alzheimer's disease with or without co-morbid depressive symptoms.
Kitzlerová E; Fisar Z; Jirák R; Zvĕrová M; Hroudová J; Benaková H; Raboch J
Neuro Endocrinol Lett; 2014; 35(1):42-9. PubMed ID: 24625917
[TBL] [Abstract][Full Text] [Related]
36. Ischemia modified albumin and plasma oxidative stress markers in Alzheimer's disease.
Can M; Varlibas F; Guven B; Akhan O; Yuksel GA
Eur Neurol; 2013; 69(6):377-80. PubMed ID: 23751563
[TBL] [Abstract][Full Text] [Related]
37. The influence of homocysteine and oxidative stress on pregnancy outcome.
Micle O; Muresan M; Antal L; Bodog F; Bodog A
J Med Life; 2012 Feb; 5(1):68-73. PubMed ID: 22574089
[TBL] [Abstract][Full Text] [Related]
38. Sialic acid, homocysteine and CRP: potential markers for dementia.
Davis G; Baboolal N; Nayak S; McRae A
Neurosci Lett; 2009 Nov; 465(3):282-4. PubMed ID: 19766699
[TBL] [Abstract][Full Text] [Related]
39. Ceruloplasmin fragmentation is implicated in 'free' copper deregulation of Alzheimer's disease.
Squitti R; Quattrocchi CC; Salustri C; Rossini PM
Prion; 2008; 2(1):23-7. PubMed ID: 19164917
[TBL] [Abstract][Full Text] [Related]
40. Age-associated changes of brain copper, iron, and zinc in Alzheimer's disease and dementia with Lewy bodies.
Graham SF; Nasaruddin MB; Carey M; Holscher C; McGuinness B; Kehoe PG; Love S; Passmore P; Elliott CT; Meharg AA; Green BD
J Alzheimers Dis; 2014; 42(4):1407-13. PubMed ID: 25024342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
